Отображение 1 - 5 результаты of 5 для поиска 'Vibhuti Vyas (15055988)', время запроса: 0.01сек. Отмена результатов
  1. 1
    Supplemental Figure S4 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S4 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... по Ibrahim Aldoss (15055961)

    Опубликовано 2025
    Другие авторы:
    Добавить в Избранное
    Сохранить в:
  2. 2
    Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S1 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... по Ibrahim Aldoss (15055961)

    Опубликовано 2025
    Другие авторы:
    Добавить в Избранное
    Сохранить в:
  3. 3
    Supplemental Figure S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S2 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... по Ibrahim Aldoss (15055961)

    Опубликовано 2025
    Другие авторы:
    Добавить в Избранное
    Сохранить в:
  4. 4
    Supplemental Figure S5 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S5 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... по Ibrahim Aldoss (15055961)

    Опубликовано 2025
    Другие авторы:
    Добавить в Избранное
    Сохранить в:
  5. 5
    Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refractory ALL

    Supplemental Figure S3 from Favorable Activity and Safety Profile of Memory-Enriched CD19-Targeted Chimeric Antigen Receptor T-Cell Therapy in Adults with High-Risk Relapsed/Refrac... по Ibrahim Aldoss (15055961)

    Опубликовано 2025
    Другие авторы:
    Добавить в Избранное
    Сохранить в:

Инструменты поиска: